Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Get Free Report) dropped 6.2% on Wednesday . The stock traded as low as $99.01 and last traded at $99.04. Approximately 938,568 shares were traded during trading, a decline of 50% from the average daily volume of 1,876,497 shares. The stock had previously closed at $105.56.
Direxion Daily S&P Biotech Bull 3x Shares Stock Performance
The firm has a 50 day moving average of $121.65 and a 200-day moving average of $124.37.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently modified their holdings of LABU. Tidal Investments LLC purchased a new stake in shares of Direxion Daily S&P Biotech Bull 3x Shares in the third quarter worth approximately $9,012,000. Bank of New York Mellon Corp acquired a new position in Direxion Daily S&P Biotech Bull 3x Shares during the 2nd quarter valued at about $596,000. Traynor Capital Management Inc. increased its holdings in shares of Direxion Daily S&P Biotech Bull 3x Shares by 73.8% during the second quarter. Traynor Capital Management Inc. now owns 10,089 shares of the company’s stock valued at $1,144,000 after acquiring an additional 4,285 shares in the last quarter. B. Riley Wealth Advisors Inc. purchased a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares in the third quarter worth $279,000. Finally, SG Americas Securities LLC raised its stake in Direxion Daily S&P Biotech Bull 3x Shares by 49.3% in the 3rd quarter. SG Americas Securities LLC now owns 3,199 shares of the company’s stock worth $412,000 after acquiring an additional 1,057 shares during the last quarter.
About Direxion Daily S&P Biotech Bull 3x Shares
The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.
See Also
- Five stocks we like better than Direxion Daily S&P Biotech Bull 3x Shares
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- What is a buyback in stocks? A comprehensive guide for investors
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for Direxion Daily S&P Biotech Bull 3x Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3x Shares and related companies with MarketBeat.com's FREE daily email newsletter.